Breast Cancer Mammography Screening Market Size, Share & Forecast 2034

Breast Cancer Mammography Screening Industry Prospective:

The global breast cancer mammography screening market size was worth around USD 4.10 billion in 2024 and is predicted to grow to around USD 7.94 billion by 2034, with a compound annual growth rate (CAGR) of roughly 8.60% between 2025 and 2034.

Request Free Sample

Breast Cancer Mammography Screening Market: Overview

Breast cancer mammography test is a preventive diagnostic procedure that detects early signs of breast cancer through low-dose radiography. It is highly recommended for females aged 40 and above to undergo screening for tumors before symptoms appear, which can significantly enhance treatment outcomes and survival rates. The global breast cancer mammography screening market is projected to witness substantial growth, driven by government-supported screening programs and technological improvements in imaging. Public health bodies in the UK, the U.S., and Australia have introduced organized breast cancer screening programs. These large-scale programs are nourishing a continuous demand for mammography testing.

Moreover, the inclination from 2D to 3D screening (digital breast tomosynthesis) has enhanced diagnostic accuracy and decreased false positives. Advancements like AI-enabled image reading and mobile or portable devices are improving clinical workflows. These innovations are appealing to health professionals, encouraging them to update their equipment to modernized technologies.

Although drivers exist, the global market is challenged by factors like radiation exposure concerns and limited access in remote areas. Although mammography utilizes low-dose radiation, exposure increases safety issues, mainly for the young female population. Clinicians and patients are concerned about the cumulative effects of radiation over time. These concerns add to screening hesitancy, especially in nations with clear risk communication.

Additionally, remote and rural areas usually lack skilled personnel, mammography infrastructure, and diagnostic facilities. Infrastructure and geographic gaps remain a significant obstacle to increasing access to screening programs globally. Even so, the global breast cancer mammography screening industry is well-positioned due to mobile and portable mammography units and AI-based decision support solutions.

Mobile mammography vans furnished with digital systems can reach underserved communities. These units are highly suitable for outreach programs in urban slums and rural areas. They enhance access, patient engagement, and early detection in low-resource settings. AI algorithms are enhancing mammography by detecting subtle abnormalities that the human eye may miss. These solutions reduce reading time, speed up workflow, and increase diagnostic confidence. The integration of AI is creating fresh value-added service models for hospitals and radiologists.

Key Insights:

• As per the analysis shared by our research analyst, the global breast cancer mammography screening market is estimated to grow annually at a CAGR of around 8.60% over the forecast period (2025-2034)
• In terms of revenue, the global breast cancer mammography screening market size was valued at around USD 4.10 billion in 2024 and is projected to reach USD 7.94 billion by 2034.
• The breast cancer mammography screening market is projected to grow significantly owing to the rising number of advocacy campaigns and awareness, integration of AI in mammography interpretation, and the surging number of outreach programs and mobile mammography units.
• Based on type, the screening mammography segment is expected to lead the market, while the diagnostic mammography segment is expected to grow considerably.
• Based on product, the Full-Field Digital Mammography (FFDM) segment leads the market, while the 3D breast tomosynthesis segment is projected to grow remarkably.
• Based on technology, the digital mammography is the dominating segment, while the 3D mammography segment is projected to witness sizeable revenue over the forecast period.
• Based on end-user, the hospitals segment is expected to lead the market compared to the diagnostic centers segment.
• Based on region, North America is projected to dominate the global market during the estimated period, followed by Europe.

Breast Cancer Mammography Screening Market: Growth Drivers

Growing high-risk groups and the geriatric population drive the market growth

Aging population, mainly in the developed nations, is adding to the increased cancer burden, thus propelling the demand for routine screening, impacting the growth of the breast cancer mammography screening market. The United Nations estimates that by 2030, one in six individuals will be aged 60 or older, a majority of whom will require screening tests.

Older ladies are at a higher risk; nearly 1 in 27 females aged 60 will be diagnosed with breast cancer, compared to 1 in 204 for females aged 30, as per BreastCancer.org.

Technological improvements in mammography fuel the market growth

The shift to digital Mammography, AI-based image processing, and 3D mammography is transforming the screening outlook. The advanced technologies offer fewer false positives, improved diagnostic accuracy, and higher sensitivity, especially for females with dense breast tissue.

Hologic introduced its novel 3DimensionsTM mammography system with Clarity HDTM high-resolution imaging in March 2024, which is presented to detect up to 65% more invasive cancers than 2D in clinical trials.

Breast Cancer Mammography Screening Market: Restraints

Fear of overdiagnosis and radiation exposure concerns adversely impact the market progress

Though mammography is considered safe, issues regarding radiation exposure, overdiagnosis, and false positives prevail among healthcare providers and patients. Cumulative radiation from repeated screenings could be a hesitation factor, mainly among younger women and those at less risk. According to a 2023 report from the USPSTF, for every 1,000 women screened over 10 years, more than 100 may experience at least one false positive.

Breast Cancer Mammography Screening Market: Opportunities

Expansion of deep learning and AI integration in mammography positively impacts market growth

Deep learning and artificial intelligence algorithms are transforming breast cancer screening by improving image interpretation, optimizing radiologist workloads, and reducing false positives. The integration of AI represents a major opportunity for the breast cancer mammography screening industry, mainly due to the global scarcity of radiologists.

GE Healthcare collaborated with Koios Medical to integrate AI into its mammography systems in January 2024, aiming for more confident and faster diagnoses.

Breast Cancer Mammography Screening Market: Challenges

Training gaps and workforce shortages in imaging and radiology restrict the market growth

The breastfeeding domain experiences a concerning shortage of mammography technologists and trained radiologists, resulting in overburdened screening centers. This challenge is particularly acute in both developing and developed nations.

The Royal College of Radiologists, United Kingdom, warned that approximately 40% of NHS breast cancer screening units reported disparaging staffing shortages, resulting in increased waiting times and backlogs in mammogram interpretation.

Request Free Sample

Breast Cancer Mammography Screening Market: Report Scope

Breast Cancer Mammography Screening Market: Segmentation

The global breast cancer mammography screening market is segmented based on type, product, technology, end-user, and region.

Based on type, the global breast cancer mammography screening industry is divided into screening mammography and diagnostic mammography. The screening mammography segment registered a notable market share owing to its broader use in routine breast cancer detection, mainly among asymptomatic females.

On the other hand, the diagnostic mammography segment holds a second-leading share. It is primarily used for females who exhibit symptoms, such as abnormalities or lumps, detected during screening mammograms.

Based on product, the global industry is segmented into film-screen mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, cone beam breast CT (CBCT), and others. The full-field digital mammography (FFDM) segment registers a substantial share because of its superior image quality, efficient storage, and faster processing than conventional film-screen systems.

Nonetheless, 3D breast tomosynthesis, also known as Digital Breast Tomosynthesis, ranks second due to its improved precision and ability to detect cancers in dense breast tissue.

Based on technology, the global breast cancer mammography screening market is segmented as analog Mammography, digital Mammography, 3D Mammography, and others. The digital mammography segment leads the global market, fueled by its broader adoption, low radiation dose, seamless data storage and transmission potential, and better image clarity.

However, the 3D mammography segment holds the second position. It is speedily gaining traction because of its high cancer detection rates and potential to reduce false positives, mainly in females with dense breast tissue.

Based on end user, the global market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and others. The hospitals segment leads the global market because of their advanced infrastructure, high patient inflow for follow-ups and routine screenings, and extensive diagnostic capabilities.

Conversely, the diagnostic centers segment is expected to grow considerably over the coming years. They offer specialized imaging services with short wait times and higher affordability, mainly in semi-urban and urban areas.

Breast Cancer Mammography Screening Market: Regional Analysis

North America to witness significant growth over the forecast period

North America is likely to maintain its leadership in the global breast cancer mammography screening market due to high incidences of breast cancer, a well-developed healthcare infrastructure, and a high adoption of AI-based and 3D mammography. North America has one of the highest rates of breast cancer across the globe, especially in the United States.

An estimated 3,10,720 fresh cases of invasive breast cancer are projected to be diagnosed in U.S. females in 2025, according to the American Cancer Society. This burden propels strong demand for routine and improved mammography screening services. North America holds a well-established healthcare system with broader availability of 3D and digital mammography equipment. Diagnostic centers and hospitals are furnished with the latest imaging technologies. This infrastructure enables high-quality screening, significantly contributing to the region's dominance.

Additionally, North American providers are among the early adopters of 3D breast tomosynthesis and AI-based diagnostic systems. Firms like GE Healthcare and Hologic dominate the regional industry, driven by continuous advancements. These improvements enhance diagnostic precision and fuel higher revenue per screening.

Europe continues to hold the second-highest share in the breast cancer mammography screening industry, owing to well-established population-based screening programs, robust EU and government funding support, and advanced healthcare across the region. A majority of European nations have government-funded and organized cancer screening initiatives, targeting females aged 50-69. For instance, the United Kingdom’s NHS Breast Cancer Screening Programme invites ladies for a mammogram every 3 years. These structured programs promise broader access and continuous participation in screening throughout the region.

Additionally, the European Commission supports prevention through programs such as Europe's Beating Cancer Plan, allocating EUR 4 billion to combat cancer. Some portion of this funding is allocated to enhancing early detection infrastructure. Government investment is the key propeller in sustaining and expanding mammography access.

Moreover, Western Europe leverages highly developed healthcare technologies, trained professionals, and advanced radiology departments. Nations like Switzerland and Germany are home to prominent radiology training centers. This strong foundation allows the effective delivery of screening facilities and aids innovations.

Breast Cancer Mammography Screening Market: Competitive Analysis

The key operating players in the global breast cancer mammography screening market include:

• Hologic Inc.
• GE HealthCare
• Siemens Healthineers
• Fujifilm Holdings Corporation
• Canon Medical Systems Corporation
• Koninklijke Philips N.V.
• Carestream Health
• Allengers Medical Systems Ltd.
• Metaltronica S.p.A.
• Delphinus Medical Technologies
• ScreenPoint Medical
• Koning Corporation
• Dilon Technologies Inc.
• Agfa-Gevaert Group
• Aurora Imaging Technology Inc.

Breast Cancer Mammography Screening Market: Key Market Trends

Expansion of portable and mobile mammography units:

To address access concerns in underserved and rural areas, mobile mammography vans furnished with portable or digital systems are being used. These units enable mass screenings in community settings, driving early detection in remote populations. NGOs and governments are investing in mobile outreach to diminish the screening gap.

Risk-based and personalized screening models:

There is an increasing move towards risk-adapted models that consider family history, lifestyle, and genetic factors. Females with BRCAI/2 mutations or dense breast tissue are suggested for alternative or more frequent screenings. This personalized approach optimizes resource allocation and improves screening accuracy.

The global breast cancer mammography screening market is segmented as follows:

By Type

• Screening Mammography
• Diagnostic Mammography

By Product

• Film-Screen Mammography
• Full-Field Digital Mammography (FFDM)
• 3D Breast Tomosynthesis
• Cone Beam Breast CT (CBCT)
• Others

By Technology

• Analog Mammography
• Digital Mammography
• 3D mammography
• Others

By End User

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa